Juleen R Zierath

Juleen R Zierath is a Professor at the University of Copenhagen's Faculty of Health and Medical Sciences, where she leads the Zierath Group at the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR). Her research focuses on the molecular mechanisms underlying metabolic diseases, particularly diabetes and insulin resistance.

Professor Zierath's research interests center on skeletal muscle metabolism, circadian regulation of metabolic processes, and the molecular basis of insulin resistance. Her work bridges basic science with clinical applications, investigating how exercise, circadian rhythms, and metabolic pathways interact to influence cardiometabolic health. Current research explores time-of-day effects on exercise metabolism, molecular signatures of diabetes, and the role of specific transcription factors in metabolic regulation.

Analysis of her recent publications reveals a strong focus on molecular and cellular mechanisms of metabolism, with particular emphasis on skeletal muscle as a key metabolic tissue. Her work spans from basic molecular studies to translational research with clinical implications for diabetes treatment. The research employs advanced techniques including phosphoproteomics, metabolomics, and in vitro and in vivo models to understand metabolic regulation.

Professor Zierath maintains an active research program with extensive collaborations, as evidenced by her numerous high-impact publications in top-tier journals including Cell, Nature Metabolism, PNAS, and Cell Metabolism. Her work has significant implications for understanding the pathophysiology of metabolic diseases and developing targeted interventions.

The Zierath Group operates within the CBMR at the University of Copenhagen, a leading research center focused on basic metabolic research with translational potential. The group utilizes state-of-the-art methodologies to investigate metabolic regulation at molecular, cellular, and organismal levels, with particular focus on skeletal muscle metabolism and its role in metabolic health and disease.